Spyre Therapeutics Insider Trades
NASDAQ: SYREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 82 · $439.75M
- Shares bought / sold
- 0 / 5.18M
- Net activity
- Net selling $439.7 million
Spyre Therapeutics insider activity
Over the last 12 months, Spyre Therapeutics insiders reported 100 transactions on SEC Form 4: 0 open-market purchases and 82 sales. Insiders bought $0 and sold $439.7 million worth of stock, for net insider selling of $439.7 million. The largest seller was Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Kiselak Tomas & Harwin Peter Evan, with $399.7 million in reported sales.
The most recent filing shows King-Jones Heidy (See Remarks) reporting a transaction in 28,933 shares at $14.50 on Oct 1, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put SYRE's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
SYRE insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 100 | $9.39K | Form 4 |
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 4,990 | $465.92K | Form 4 |
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,989 | $368.22K | Form 4 |
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 2,638 | $241.35K | Form 4 |
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 2,683 | $241.74K | Form 4 |
| Oct 1, 2026 | Turtle CameronChief Executive Officer | Sale | 600 | $53.48K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 229 | $21.43K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 3,071 | $285.45K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 2,100 | $193.03K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 1,500 | $135.41K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 600 | $53.44K | Form 4 |
| Oct 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Sale | 2,600 | $243.00K | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Sale | 2,100 | $194.67K | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Sale | 7,228 | $660.28K | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Sale | 16,605 | $1.50M | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Sale | 400 | $35.70K | Form 4 |
| Oct 1, 2026 | King-Jones HeidySee Remarks | Option exercise | 28,933 | $419.53K | Form 4 |
| Sep 30, 2026 | Burrows Scott LChief Financial Officer | Sale | 17,500 | $1.57M | Form 4 |
| Sep 30, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 17,500 | $253.75K | Form 4 |
| Sep 2, 2026 | Burrows Scott LChief Financial Officer | Sale | 18,232 | $1.63M | Form 4 |
| Sep 2, 2026 | King-Jones HeidySee Remarks | Sale | 400 | $36.00K | Form 4 |
| Sep 2, 2026 | King-Jones HeidySee Remarks | Option exercise | 400 | $5.80K | Form 4 |
| Sep 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 200 | $17.81K | Form 4 |
| Sep 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 2,016 | $177.47K | Form 4 |
| Sep 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 4,384 | $381.89K | Form 4 |
| Sep 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 900 | $77.63K | Form 4 |
| Sep 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| Sep 1, 2026 | King-Jones HeidySee Remarks | Sale | 400 | $35.75K | Form 4 |
| Sep 1, 2026 | King-Jones HeidySee Remarks | Sale | 6,206 | $547.18K | Form 4 |
| Sep 1, 2026 | King-Jones HeidySee Remarks | Sale | 16,548 | $1.44M | Form 4 |
| Sep 1, 2026 | King-Jones HeidySee Remarks | Sale | 4,845 | $418.61K | Form 4 |
| Sep 1, 2026 | King-Jones HeidySee Remarks | Option exercise | 27,999 | $405.99K | Form 4 |
| Sep 1, 2026 | Turtle CameronChief Executive Officer | Sale | 400 | $35.63K | Form 4 |
| Sep 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,700 | $325.82K | Form 4 |
| Sep 1, 2026 | Turtle CameronChief Executive Officer | Sale | 8,400 | $732.06K | Form 4 |
| Sep 1, 2026 | Turtle CameronChief Executive Officer | Sale | 2,500 | $215.90K | Form 4 |
| Aug 7, 2026 | Albers Jeffrey W.Director | Sale | 10,000 | $1.05M | Form 4 |
| Aug 7, 2026 | Albers Jeffrey W.Director | Sale | 8,000 | $835.04K | Form 4 |
| Aug 7, 2026 | Albers Jeffrey W.Director | Sale | 5,000 | $522.35K | Form 4 |
| Aug 7, 2026 | Albers Jeffrey W.Director | Option exercise | 5,000 | $51.95K | Form 4 |
| Aug 3, 2026 | Turtle CameronChief Executive Officer | Sale | 16 | $1.56K | Form 4 |
| Aug 3, 2026 | Turtle CameronChief Executive Officer | Sale | 1,392 | $134.77K | Form 4 |
| Aug 3, 2026 | Turtle CameronChief Executive Officer | Sale | 5,635 | $540.57K | Form 4 |
| Aug 3, 2026 | Turtle CameronChief Executive Officer | Sale | 7,157 | $680.63K | Form 4 |
| Aug 3, 2026 | Turtle CameronChief Executive Officer | Sale | 800 | $75.18K | Form 4 |
| Aug 3, 2026 | Burrows Scott LChief Financial Officer | Sale | 100 | $9.71K | Form 4 |
| Aug 3, 2026 | Burrows Scott LChief Financial Officer | Sale | 2,300 | $221.49K | Form 4 |
| Aug 3, 2026 | Burrows Scott LChief Financial Officer | Sale | 5,100 | $485.57K | Form 4 |
| Aug 3, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| Jul 1, 2026 | Turtle CameronChief Executive Officer | Sale | 590 | $52.46K | Form 4 |
| Jul 1, 2026 | Turtle CameronChief Executive Officer | Sale | 4,234 | $373.10K | Form 4 |
| Jul 1, 2026 | Turtle CameronChief Executive Officer | Sale | 10,176 | $889.79K | Form 4 |
| Jul 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 1,725 | $152.44K | Form 4 |
| Jul 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 5,775 | $505.60K | Form 4 |
| Jul 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| Jul 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 1,834 | $162.02K | Form 4 |
| Jul 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 6,500 | $568.88K | Form 4 |
| Jul 1, 2026 | Sloan SheldonChief Medical Officer | Option exercise | 8,334 | $228.85K | Form 4 |
| Jun 25, 2026 | Burrows Scott LChief Financial Officer | Sale | 10,000 | $871.40K | Form 4 |
| Jun 25, 2026 | Burrows Scott LChief Financial Officer | Sale | 5,000 | $435.60K | Form 4 |
| Jun 25, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 15,000 | $217.50K | Form 4 |
| Jun 23, 2026 | Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Kiselak Tomas & Harwin Peter EvanDirector | Sale | 4,684,781 | $399.66M | Form 4 |
| Jun 23, 2026 | Fairmount Funds Management LLC & Fairmount Healthcare Fund II L.P. & Kiselak Tomas & Harwin Peter EvanDirector | Conversion | 666,680 | — | Form 4 |
| Jun 22, 2026 | HENDERSON MICHAEL THOMASDirector | Sale | 20,000 | $2.00M | Form 4 |
| Jun 3, 2026 | Sloan SheldonChief Medical Officer | Sale | 8,333 | $624.98K | Form 4 |
| Jun 3, 2026 | Sloan SheldonChief Medical Officer | Option exercise | 8,333 | $228.82K | Form 4 |
| Jun 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,294 | $235.13K | Form 4 |
| Jun 1, 2026 | Turtle CameronChief Executive Officer | Sale | 8,149 | $574.50K | Form 4 |
| Jun 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,557 | $246.86K | Form 4 |
| Jun 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 3,100 | $223.39K | Form 4 |
| Jun 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 2,599 | $183.93K | Form 4 |
| Jun 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 1,801 | $125.62K | Form 4 |
| Jun 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| May 8, 2026 | HENDERSON MICHAEL THOMASDirector | Sale | 19,269 | $1.45M | Form 4 |
| May 8, 2026 | HENDERSON MICHAEL THOMASDirector | Sale | 24,814 | $1.86M | Form 4 |
| May 8, 2026 | HENDERSON MICHAEL THOMASDirector | Sale | 33,513 | $2.47M | Form 4 |
| May 8, 2026 | HENDERSON MICHAEL THOMASDirector | Sale | 2,404 | $174.46K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 300 | $22.49K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 1,700 | $126.19K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,100 | $226.73K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 1,000 | $71.76K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 3,600 | $254.77K | Form 4 |
| May 1, 2026 | Turtle CameronChief Executive Officer | Sale | 5,300 | $368.56K | Form 4 |
| May 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 12,500 | $892.13K | Form 4 |
| May 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 12,500 | $181.25K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 400 | $30.15K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 5,059 | $377.40K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 10,358 | $763.80K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 12,777 | $931.95K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 8,777 | $628.08K | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 19,656 | $1.39M | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 21,306 | $1.48M | Form 4 |
| May 1, 2026 | Sloan SheldonChief Medical Officer | Option exercise | 78,333 | $2.15M | Form 4 |
| Apr 1, 2026 | Burrows Scott LChief Financial Officer | Sale | 6,200 | $305.10K | Form 4 |
| Apr 1, 2026 | Burrows Scott LChief Financial Officer | Option exercise | 7,500 | $108.75K | Form 4 |
| Apr 1, 2026 | Sloan SheldonChief Medical Officer | Sale | 7,958 | $397.90K | Form 4 |
| Apr 1, 2026 | Sloan SheldonChief Medical Officer | Option exercise | 7,958 | $172.37K | Form 4 |
| Apr 1, 2026 | Turtle CameronChief Executive Officer | Sale | 2,656 | $132.59K | Form 4 |
| Apr 1, 2026 | Turtle CameronChief Executive Officer | Sale | 12,344 | $607.32K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4